Avondale Pharmaceuticals, LLC signs development agreement with Oxford Pharmaceuticals, LLC

    Avondale Pharmaceuticals, LLC signs development agreement with Oxford Pharmaceuticals, LLC

    Avondale Pharmaceuticals, LLC signs development agreement
    with Oxford Pharmaceuticals, LLC

    BIRMINGHAM, Ala., July 17, 2018 /PRNewswire/ — Avondale Pharmaceuticals, LLC,
    announced today an exclusive, product development partnership with Oxford Pharmaceuticals,
    a pharmaceutical manufacturer and distributor based in Birmingham, AL. John Schultz,
    President of Oxford said “Oxford is extremely pleased to continue its relationship with Avondale
    through this partnership to advance the capabilities and experience of the Oxford staff providing
    high quality products. The partnership will enable Avondale to continue to bring unique and
    high quality drug products to market for patients across the U.S.”
    About Oxford Pharmaceuticals, LLC

    Oxford Pharmaceuticals is a manufacturer and distributor of generic pharmaceutical products
    with a new state of the art manufacturing facility. Oxford’s capabilities include drug
    development, contract manufacturing and packaging including serialization.
    About Avondale Pharmaceuticals, LLC

    Avondale is an innovative U.S. distributor of specialty branded pharmaceutical products across
    several therapeutic categories. Avondale specializes in identifying and bringing to market
    quality, affordable products to customers and patients.

     

    For additional information please contact Avondale at 800-528-3058 or
    visit www.avondalepharm.com.
    SOURCE Avondale Pharmaceuticals, LLC

    Leave a Reply

    Your email address will not be published. Required fields are marked *